Allergic rhinitis (AR) can cause significant olfactory loss, but few studies have specifically investigated AR effects on olfactory and nasal respiratory tissues per se. To address this, we used a murine AR protocol employing nasal allergen infusion for both sensitization and challenges. Seven-to 11-week BALB/c mice were bilaterally infused with 1% ovalbumin (OVA) in phosphate-buffered saline (PBS) or PBS alone for 6 or 11 weeks, given single bilateral PBS or OVA infusions 24 h before sacrifice, or left untreated. High OVA-specific IgE serum levels and eosinophil infiltration confirmed AR induction. Olfactory (OE) and respiratory (RE) epithelia showed distinctly different responses, most conspicuously, massive eosinophil infiltration of immediately RE-subjacent lamina propria. In OE, such infiltration was minimal. Significant RE hypertrophy and hyperplasia also occurred, although OE organization was generally maintained and extensive disruption localized despite a 20% reduction in sensory neurons and globose basal cells after 11 weeks OVA. Pronounced Bowman's gland hypertrophy crowded both OE and olfactory nerve bundles. Cellular proliferation was widely distributed in RE but in OE was localized to normally thinner OE and RE-proximal OE, suggesting possible indirect RE influences. Terminal deoxynucleotide transferase (TdT) nick end labeling was greater in OE than RE and, in contrast to other effects, occurred with acute infusions and chronic PBS alone, often unilaterally. Following chronic OVA, AR-related bilateral increases appeared superimposed on those. These findings indicate AR effects on olfactory function may be complex, reflecting various levels of RE/OE responses and interactions.
Introduction
Allergic rhinitis (AR) is the most common atopic disease (McCusker et al. 2002) and often leads to significantly reduced olfactory capabilities (Baroody and Naclerio 1991; Apter et al. 1995) . To begin to examine AR effects on olfaction in a model system, we adapted the murine in situ nasal sensitization and challenge AR protocol of McCusker et al. (2002) and examined consequent nasal epithelial changes. The protocol involves intranasal delivery of small amounts of allergen for both sensitization and challenges, the rationale being that this more closely reflects natural human AR and asthma induction than do other murine models which rely on systemic sensitization (intraperitoneal or subcutaneous, with or without adjuvant) with only the subsequent challenges being nasal and often involving relatively large infusate volumes (e.g., Sato et al. 1999; Saito et al. 2001; Martin et al. 2005; Rahman et al. 2006; Ozaki et al. 2010) . The use of a nonmicrobially derived allergen (ovalbumin, OVA) also avoids possible complications arising from use of microbial allergens, which may evoke additional innate, non-AR immune responses to specific microbe-associated molecular patterns (e.g., van de Rijn et al. 1998; Okano et al. 1999; Epstein et al. 2008) . Using their protocol, McCusker et al. showed elevation of serum allergen-specific IgE and IgG levels, pronounced upper and lower airway eosinophil infiltration, and increased IL-5 and polymorphonuclear leukocyte presence in postchallenge bronchoalveolar lavage fluid, all indicators of AR. A more detailed histological analysis, however, was not carried out, especially with regard to olfactory (OE) and respiratory (RE) epithelia.
We have now undertaken such an analysis and have also included an additional longer period of allergen challenge, as might occur with chronic or perennial allergen exposure. We find distinct RE and OE histological changes, RE-specific eosinophil lamina propria infiltration, and possibly enhanced OE changes in areas of closer than more distant RE proximity. Such findings suggest that nasal AR responses involve RE/OE and immune system interactions and that AR-related olfactory functional changes likely reflect events at multiple levels.
Materials and methods

Animals
Virus-free 7-11-week-old BALB/c mice (Charles River) were housed under conventional conditions in the Northwestern University animal facility. BALB/c mice were used because this strain had been found in studies using the Schistosoma mansoni egg antigen as the allergen to give more robust AR responses than either C57BL/6 or CBA/J mice (Okano et al. 1999) . All procedures were carried out in accordance with the National Institutes of Health ''Guide for the Care and Use of Laboratory Animals'' and Northwestern IUCAC.
Mice were subjected to bilateral infusion of 7.5 lL of either filter-sterilized 1.0% ovalbumin (OVA; Grade V; Sigma) in phosphate-buffered saline pH 7.4 (PBS, prepared from a concentrate [OmniPur, EMD Chemicals]) or PBS alone. To maximize nasal cavity fluid dispersal, animals were gently held on their backs during infusion and maintained in that position until their efforts to expel the infusate ceased. Infusions followed the protocol in Figure 1a . Chronically exposed mice were treated for 6 or 11 weeks and sacrificed 1 day after the last infusion. Week 3 of the regimen was a rest period followed by single bilateral infusions on the Monday of Week 4. This third to fourth week break was found essential for maximizing immune responses at sacrifice in Week 6 (McCusker et al. 2002) . In our extension of the McCusker et al. protocol to 11 weeks, we have included a similar break in Weeks 8-9. Acutely exposed mice received single bilateral OVA or PBS infusions followed by sacrifice 1 day later. Untreated control mice received neither OVA nor PBS prior to sacrifice. Two series of mice were processed, with a total of 50 animals overall (Figure 1b) .
At the time of sacrifice, animals were deeply anesthetized with ketamine and xylazine (0.65 mg and 0.035 mg/g b.wt., respectively), blood collected by cardiac puncture, and the animals transcardially perfused with PBS followed by 4% paraformaldehyde in PBS. Following overnight postfixation at 4 �C in 4% paraformaldehyde, heads were trimmed, decalcified (Series I, 4 h, RDO [Apex Engineering]; Series II, 2 days, 2% Na citrate/4% formic acid), embedded in Paraplast (Oxford Labware), and sectioned coronally at 8 lm through the entire anterior-posterior extent of the nasal cavity. To examine nasal cell proliferation, Series II animals were injected with the thymidine analog 5-bromo-2#-deoxyuridine (BrdU; 0.05 mg/g b.wt. ip.; Sigma-Aldrich) 2 h prior to fixation.
Histology
For orientation and overall nasal histological examination of each animal, sections separated by 500-800 lm through the major extent of the OE-containing nasal cavity were mounted on slides and stained with hematoxylin and eosin (H&E). All subsequent histological procedures were carried out on serial sections sequentially ordered to these so that all processed sections from each locale were within 60-70 lm of each other. For each histological procedure, 8-10 sections were examined per animal, extending from the most anterior appearance of endoturbinate 2 (terminology of Liebeck 1975) to the fusion of endoturbinate 4 with the cribriform plate.
Both OE and RE cell counts were carried out in the above H&E serial sections in the anterior OE-containing region, from the initial appearance of endoturbinate 2 to the fusion of its dorsal and ventral arms. Three sections, separated by at least 500 lm, were examined for each animal. Counts of nuclear profiles were made along 100 lm strips at 100· magnification. For the OE, olfactory sensory neurons (OSNs), globose basal cells, and supporting cells were counted in 2-3 septal strips situated from 200 lm above the OE/RE transition zone to the top of the septum and in one strip along the facing OE of the dorsal arm of endoturbinate 2. Septal strips were separated by at least 200 lm along the epithelial surface. In the RE, goblet and ciliated cells were counted in 2-3 strips along the septum and 1-2 strips along the RE of the facing nasal cavity wall, again situated at least 200 lm from OE/RE transition zones and separated by 200 lm. The OE counts were made in 11-week OVA-treated and untreated animals, the RE counts in 6-week OVA-treated and untreated animals, as explained in the Results. For both OE and RE, 6 OVA-treated animals and 4 untreated animals were examined, with totals of 17-23 strips for each epithelium per animal. Counts for each strip were made in triplicate and a mean calculated and tabulated. Overall means and standard errors were determined for each animal and for total values for each treatment.
The presence of eosinophils was visualized in one set of serial sections from each animal with the Luna stain (Luna 1968) . Although the Luna stains erythrocytes as well as eosinophils, PBS exsanguination prior to fixation would have removed most erythrocytes. Distribution and hypertrophy of Bowman's glands in the OE-associated lamina propria were examined with Alcian blue pH 2.5 for acid mucopolysaccharides (http://library.med.utah.edu/ WebPath/HISTHTML/MANUALS/ALCIAN.PDF) followed by H&E. Because of its OE association, Bowman's gland distribution provides a useful marker for the original location of any OE lost or replaced by RE.
Immunohistochemistry
Antibodies used were directed to BrdU (rabbit anti-BrdU, 1:1500, Abcam) and olfactory marker protein (OMP; goat anti-OMP, 1:4000, WAKO). Immunoreactivity was visualized by diaminobenzidine immunoperoxidase methodology using the appropriate Vector Elite ABC Kit with Fast Green FCF counterstaining. Antigen retrieval for BrdU immunoreactivity followed the manufacturer's directions: sections were heated in 2 N HCl 1 h at 37 �C followed by 12 min 0.1 M sodium tetraborate neutralization (pH 8.5). Sections of intestine from BrdU-injected animals served as positive controls.
Quantification of RE thickness
Measurements of RE thickness between the basement membrane and apical RE surface were made at 100· on the sections processed for anti-OMP immunohistochemistry from all Series I animals. OMP-stained sections were used to clearly distinguish between swollen RE and neighboring OE. Measurement sites in a given section were separated by at least 75 lm, giving an average of 150 measurements per animal.
TUNEL labeling for degenerating cells
Presence of degenerating cells was examined in Series II animals by terminal deoxynucleotide transferase (TdT) nick end labeling (TUNEL) procedures (ApopTag Plus Peroxidase Kit; Millipore). Three sections were processed per animal, selected to include anterior, mid, and posterior olfactory regions: regions showing, respectively, the anterior level of endoturbinate 2, the presence of all turbinates from ectoturbinate 2 through endoturbinate 3 or 4, and the region showing endoturbinate 4 just anterior to its fusion with the cribriform plate. Procedures followed manufacturer's directions except that Proteinase K was used at 7.5 lg/ mL and TdT at 1% of the final reaction mixture. Omission of TdT controlled for the enzyme. Absence of staining in the olfactory bulb and other tissues and the expected increase in ipsilateral OE labeling in sections obtained from previous bulbectomy studies (Robinson et al. 2003) served as negative and positive controls, respectively. Because of recognized TUNEL variability, primary comparisons between treatment groups were made with slides processed simultaneously.
Imaging
Images were captured on a Leica DMRB microscope equipped with a Spot Insight Color Camera using the SPOT Basic software package (Diagnostic Instruments) and processed using Adobe Photoshop programs 6 and CS2. All image adjustments are noted in the appropriate captions.
OVA-specific IgE ELISAs
The blood samples collected at sacrifice were stored undisturbed at 4 �C overnight, centrifuged (14 000 rpm, 5 min), the sera collected and stored at -80 �C, and samples analyzed by enzyme-linked immunoabsorbant assay (ELISA) for OVA-specific IgE (Mouse OVA-IgE Kit; MD Biosciences).
Statistical analysis
Quantitative data were analyzed by the Mann-Whitney test using GraphPad Prism 4 software.
Results
Induction of AR
Allergen-specific IgE levels and strong eosinophil infiltration of nasal tissue, 2 major indicators of AR induction, were both greatly increased in the chronic OVA-exposed animals and in those alone.
OVA-specific IgE ELISA
Of the five 6-week OVA serum samples giving adequate analysis volume, 4 showed noticeably increased OVA-specific IgE levels; one showed none. Overall mean value for the 4 increased samples (185.6 ± 58.9 ng/mL, mean ± standard error of the mean) was highly significant compared with the 6-week PBS or untreated control values (both 0.0 ± 0.0 ng/mL) ( Figure 2 ). All 11-week OVA samples analyzed showed large OVA-specific IgE increases and a highly significant mean increase over 11-week PBS values (5447.0 ± 2697.4 vs. 24 .0 ± 24.0 ng/mL, respectively). The 11 week levels further divided Allergic Rhinitis in Nasal Epithelia 3 into 2 response groups, one high (10 434.0 ± 3387.7 ng/mL) and one lower (460.0 ± 181.2 ng/mL). Both represent significant increases (P = 0.02). Measured IgE level of each animal correlated with its subsequently analyzed histological features. Significantly, the single low-response 6-week OVA animal above was the only chronic OVA animal to show no eosinophil infiltration or histological change. That animal was used for comparative purposes only and omitted from further analysis.
No changes occurred in PBS-or acutely OVA-treated mice compared with untreated ones.
Eosinophil infiltration
Strong eosinophil infiltration occurred bilaterally in the nasal mucosa of all chronic OVA-treated animals except the single cited above (Figure 3 ). It did not occur in any other treatment group. Significantly, infiltration was strongly localized to the RE-associated lamina propria, predominantly immediately subjacent to the basement membrane but with some more deeply scattered cells as well (Figure 3a ,b,f). In contrast, very few eosinophils occurred in sub-OE lamina propria, and most of those were scattered through the entire lamina propria rather than localized to the immediate OE-subjacent region (Figure 3a -e). The change from the RE-to the OE-associated pattern was striking and occurred within 200 lm of the RE/ OE transition (Figure 3a) . These OE/RE eosinophil distribution differences occurred uniformly throughout the entire nasal cavity. Few eosinophils occurred within the epithelia themselves ( Figure 3b ,f) or in nasal exudate (Figure 3b, d) , suggesting possibly limited epithelial access.
Histological observations
Untreated, PBS-, and acutely OVA-exposed animals All untreated animals showed histologically normal OE and RE (Figure 4 ). The OE was 60-80 l thick and its 3 constituent cell layers readily identifiable. In the OE-subjacent lamina propria, Bowman's glands were unswollen and olfactory nerve bundles compactly filled with axons. Nasal RE was 8-15 lm thick, with ciliated, goblet, and basal cells clearly distinguishable. Other than slight RE thickening (below), PBS and acute OVA animals also showed normal nasal histologies.
Figure 2 ELISA-determined mean cardiac blood serum levels of ovalbumin-specific IgE in mice treated with the various exposure protocols in Figure  1 . UNT, untreated animals; PBS, 7.5 lL PBS bilateral nasal infusions; OVA, 7.5 lL 1.0% ovalbumin bilateral nasal infusions; N = number of serum samples analyzed. Figure 3 Luna procedure-stained eosinophils (red) in nasal tissues of animals exposed to OVA for 6 (a-d) and 11 weeks (e, f). Numerous eosinophils (e.g., arrows, a, b, f) occur in the lamina propria immediately subjacent to respiratory RE but are generally absent from the OE-subjacent lamina propria (a, b, c, e), even despite obvious OE disruption (c, e). The sharpness of the subepithelial eosinophil density decrease across the RE/OE transition is apparent in the lower surface of the turbinate shown in a. Nevertheless, occasional very disrupted OE regions do show subepithelial eosinophils but with a distribution across the entire lamina propria rather than as a concentrated layer in the immediate OE-adjacent area (dotenclosed areas, d). Within the RE itself, eosinophils are rare (double arrows, b, f). Nasal exudate (asterisks, b, d) shows only occasional eosinophils (arrowheads). Shedding of multiple cells from the OE can be seen in d (double arrowhead). Brightness was enhanced in a and color adjusted in d to more readily show eosinophils. Calibration bars, a, b (for b-e), 25 lm; f, 10 lm.
RE.
The most striking nasal changes following chronic OVA exposure occurred in the RE and consisted of pronounced RE swelling (Figure 5a -e). Swelling occurred uniformly throughout the RE at both 6 and 11 weeks exposure. Widespread associated surface crenelation also occurred. Mean RE thickness increases were highly significant relative to those in both chronic PBS-treated and untreated control animals (Figure 6a, b) . As is typical in AR (e.g., Tesfaigzi et al. 2000; Rogers 2003; Locksley 2010) , pronounced goblet cell swelling and hyperplasia (below) clearly contributed to this RE hypertrophy; and although RE cell identities were readily distinguishable at 6 weeks ( Figure 5c ), the swelling rendered them much less so at 11 weeks ( Figure 5d ). Confirming these observations, RE cell counts in 6-week OVA-treated mice showed highly significant increases in cell numbers ( Figure 6c ). Moreover, while the number of goblet and ciliated cells/100 lm increased 1.6-fold over untreated animals (59.5 ± 1.5 vs. 36.7 ± 1.0), the number of goblet cells alone increased 3.4-fold (24.2 ± 0.6 vs. 7.0 ± 0.3), and percentage of cells that were goblet cells increased 2.2-fold (42.4 ± 1.1 vs. 19.5 ± 0.8).
Unexpectedly, RE thickening also occurred with PBS and acute OVA treatments ( Figure 6b ). Increased thickness was not strikingly obvious on visual observation ( Figure 5e ); but all increases were highly significant, likely due to the large measurement numbers (200-450 per treatment group). Postinfusion time of onset of this non-AR-related swelling is not Figure 4 . (a and b) Low magnifications from 6-(a) and 11-week (b) chronic OVA animals. RE swelling is apparent even at this magnification as is nasal exudate (asterisks) in the nasal cavity. Even at 11 weeks, OE changes are much less obvious (arrowheads, b). Nasal sinus epithelial swelling can also be seen. (c-e) Higher magnification through the RE of 6-and 11-week OVA-and 11-week PBS-exposed animals (c, d, e, respectively). Pronounced RE goblet cell swelling with surface crenelation occurs in chronic OVA animals. Surface blebbing is also apparent (arrowheads, c, d). At 6 weeks OVA exposure, goblet and ciliated cells can still be readily distinguished, but by 11 weeks, goblet cell hypertrophy makes this difficult. Slight RE hypertrophy relative to untreated control RE (Figure 4c ) also occurs with chronic PBS treatment. (f-k) Higher magnifications through OE following chronic OVA exposure. (f, g) Most OE appears grossly normal at both chronic exposure periods. However, Bowman's glands are greatly swollen and appear to crowd olfactory nerve bundles in the lamina propria, especially by 11 weeks exposure (g). Disruptive BG protrusion into overlying OE also occurs (arrowheads, f, g). Nerve bundles appear much less densely packed than those of control animals (cf. Figure 4b ). Small tears can also cross the OE (small arrows, g). (h-k) Small areas of OE also show more pronounced changes, including distinct thinning (h, i, between arrows) and presence of invaginated lacunae (arrowhead, j). Areas of cellular hypertrophy also occur, as seen in OE on a ventral, concave turbinate surface (asterisk) where OE is normally quite thin (k). (l) By 11 weeks OVA exposure OE disruption was often more noticeable in RE-proximal regions (center, between arrowheads) than more distally (to right). (m, n) Alcian blue-stained sections through the septal organ region (SO) of untreated control (m) and 11-week chronic OVA (n) animals. In chronic OVA animals, the SO itself completely disappears and is replaced by swollen RE, its original location indicated only by the presence of Alcian blue-stained Bowman's glands. Note, image sharpness was increased in k. Brightness and contrast were also adjusted over the entire figure. Calibration bars, a, 250 lm for a, b; c, 25 lm for c-e; f, 25 lm for f, g, i-n; h, l, 50 lm.
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OE. In contrast to the uniform RE swelling, OVA-related OE changes were less obvious and more variable; and in most locales, OE appeared grossly normal ( Figure  5a ,b,f,g). Nevertheless, cell counts in such apparently normal areas at 11 weeks OVA showed a highly significant 20% decrease in mean density of OSNs plus globose basal cells in OVA-treated versus untreated mice (134.7 ± 4.0 and 169.4 ± 4.1 cells/100 lm, respectively; Figure 6d ). In contrast, supporting cell density in these areas remained unchanged (21.1 ± 0.4 vs. 21.6 ± 0.5 cells/100 lm). Counts were made at 11 weeks to maximize the possible differences.
Some increased tearing may occur in these grossly normal areas as well (Figure 5g ). Although such tearing often occurs in sectioned epithelial material, it seemed more frequent in the chronic AR OE, suggesting possibly weakened intercellular connections.
In addition, however, scattered small areas of much more noticeable OE thinning, reduced cell density, and distinct disruption or loss of normal OE organization also occurred in chronic OVA animals (Figure 5h-k) . Such areas were more obvious with 11 weeks than 6 weeks OVA treatment. By 11 weeks, areas of cellular hypertrophy also appeared (Figure 5k) . By their location, the swollen cells appear to be OSNs, but further examination is needed to confirm that they do not represent goblet cell metaplasia to the OE or even swollen supporting cell basal processes.
Interestingly, in many animals, OE disruption appeared somewhat greater in more RE-proximal regions ( Figure  5l ), regardless of nasal cavity location. An extreme example of this is disappearance of the septal organ, a small OE-containing structure situated in the ventral midseptal RE (Figure  5m,n) . In all 11-week OVA animals for which examined sections included this region, the septal organ had been replaced by hypertrophied RE, its original location indicated only by the presence of subepithelial Bowman's glands. A proximity effect was also noticed with BrdU labeling (below).
Except for this possible RE proximity effect, no obvious inter-or intra-animal uniformity occurred in either the degree or nasal distribution of this more pronounced OE disruption. Rather, histological changes occurred on an individual nasal cavity basis, likely reflecting individual infusion specifics.
Nasal exudate. Despite fixation by transcardial perfusion, noticeable cellular exudate occurred in nasal cavities of several chronic OVA-treated mice (e.g., Figures 3b,d,  5a,b, 9h, 10a,b) . This was more pronounced at 11 weeks and in animals showing greater epithelial disorganization. Cells could be seen blebbing from both OE and RE (Figures 5c,d, 10b) .
Changes in the OE-associated lamina propria. In contrast to the somewhat limited and variable histological changes in the OE itself, the OE-associated subepithelial Bowman's glands showed pronounced swelling throughout the nasal cavity in chronic OVA animals, apparent in both H&E and Alcian blue preparations (Figures 5f,g and 7) . This was greater with 11 than 6 weeks exposure. Swollen acinar regions appeared to both severely crowd neighboring olfactory nerve bundles and to encroach disruptively into the OE (Figures 5f,g,m,n and 7i). Alcian blue staining revealed some slight swelling in chronic PBS animals as well ( Figure  7e ,f), but no impingement on olfactory nerve bundles or OE. Swelling was minimal with acute PBS or OVA exposure. Possible AR-related Bowman's gland swelling has been previously noted (Getchell and Mellert 1991) but only recently documented (Ozaki et al. 2010) , although in the latter report Bowman's glands were not specifically identified as such.
Olfactory nerve bundles also showed reduced axonal packing in chronic OVA mice compared with the other treatment groups, especially at 11weeks exposure (cf. Figure 5f ,g with Figure 4b ).
Cellular dynamics
Because of the significant RE thickening and the reduced OE cell densities in chronic OVA animals, as well as the well-known changes in OE cellular dynamics following various experimental manipulations (e.g., Graziadei and Monti Graziadei 1978, 1980; Costanzo and Graziadei 1983; Costanzo 1984; Farbman et al. 1988; Carr and Farbman 1992, 1993; Schwob et al. 1992) , OE and RE proliferative and degenerative activities were examined in all Series II animals.
Proliferative activity
Untreated animals showed few or no BrdU-labeled cells, and those few were predominantly located in the OE basal cell layer, as expected (Moulton et al. 1970; Graziadei 1973; Graziadei and Monti Graziadei 1978) (Figure 8a,d) . The same was true for OVA-acutely exposed and all PBS animals. Thus, neither PBS infusion alone nor acute OVA exposure affects OE or RE proliferative activity.
In contrast, chronic OVA exposure caused noticeable BrdU labeling (Figure 8b,c) . This occurred primarily in the RE, particularly in strips of contiguous cells with either apically or basally situated nuclei (Figure 8f,g ). Goblet cell labeling predominated, but ciliated and some basal cell labeling also occurred, in agreement with the RE cell counts. The large amount of goblet cell labeling reflects goblet cell hyperplasia and likely metaplasia (Rogers 2003; Locksley 2010) , which would contribute to both RE swelling and increased mucus production. Absence of RE labeling in all other groups indicates that their slight RE swelling reflects cellular hypertrophy alone rather than hyperplasia.
In the OE, BrdU labeling remained primarily in scattered single basal cells in all treatment groups, (Figure 8b-e) . However, chronic OVA mice also showed localized OE regions with apical and/or basal strips of contiguously labeled cells, similar to that in RE, especially in RE-adjacent areas and areas of normally thin OE, such as the concave lateral turbinate surfaces (Figure 8b ,c,h-j). In animals showing (g-i) Higher magnifications of OE from untreated and chronically OVAexposed animals show the distinct swelling in the lamina propria at 6 weeks and swelling into the OE itself at 11 weeks. In the latter image, the OE shows extreme disruption and disruption of OE/lamina propria boundaries. Image contrast and brightness have been adjusted over the entire figure. Calibration bars, a (for a-f), 250 lm; g (for g-i), 25 lm.
Allergic Rhinitis in Nasal Epithelia 7 greater epithelial disruption, the BrdU-labeled cell strips were more numerous and widespread, including in areas of normally thicker OE that had thinned (Figure 8k ). Strips were generally longer and more widespread at 11 weeks OVAs than at 6 weeks OVA (cf. Figure 8b ,c,j). Strip length also appeared greater in animals with higher RE-associated eosinophil levels and OVAspecific IgE titers.
The identity of labeled cells in the OE strips was not always clear, a fact worsened by cellular swelling. In some areas, cell identity was apparent from cell location, as with strips of labeled supporting or basal cells (Figure 8h,i) , although many of the apparent supporting cells showed abnormally apically situated nuclei with a smaller supranuclear cytoplasmic region than normal. In other areas, however, especially those with more damage, cell identity was uncertain (Figure 8f-i,k,l) . Cell-specific markers are needed to address this issue.
Interestingly, in contrast to the scattered single BrdU-labeled basal cells (above), in which nuclear labeling was sharply defined (Figure 8d ,e), labeling in all BrdU-labeled cell strips was diffuse and somewhat faint (Figure 8f-i ). This likely reflects nuclear swelling and consequent label dispersal within the swollen nuclei: similarly increased intranuclear dispersal and reduced staining intensity in the swollen nuclei occurred using the Feulgen stain, a DNA label (not shown). Labeled cells do not appear necrotic: the diffuse BrdU label always appeared membrane-bound at high magnification. No obvious macrophage infiltration into these areas was observed either. Ultrastructural examination is needed.
Bowman's glands showed no BrdU labeling (Figure 8h ,k), indicating that their pronounced swelling reflects acinar cell hypertrophy alone.
Few BrdU-labeled cells were seen in the nasal exudate (Figure 8l ).
Degenerative activity
TUNEL labeling patterns (Figure 9 ) differed noticeably from those of BrdU. First, although only the expected minimal labeling occurred in untreated controls (Figure 9a ), TUNEL labeling was seen in all other treatment groups (Figure 9b-h ). Such labeling in PBS and acute OVA animals, in clear absence of eosinophil infiltration or elevated IgE titers, indicates that not all TUNEL labeling reflects an AR response. Some must result from fluid infusion alone, with AR-related responses superimposed on that.
TUNEL effects of fluid infusion with AR effects superimposed help explain several other observations, especially when considered in conjunction with the nasal patency cycle (Bojsen-Møller and Fahrenkrug 1971) . First, TUNEL labeling in PBS and acute OVA animals tended to be more unilateral than in chronic OVA animals (Figure 9b-g ). Second, overall labeling levels with both PBS and OVA were generally higher in the chronically than acutely treated animals (Figure 9b-g ). Third, although noticeable interanimal variability occurred in all treatment groups, the degree (a-c) Low magnification nasal cavity images showing the dorsal limits of RE (arrows) and the distribution of OE elsewhere (arrowheads). Untreated animals (a), as well as PBS-and acutely OVA-treated animals (not shown), show no labeling except in scattered OE basal cells, better seen at higher magnification (d). In contrast, following chronic OVA exposure, strips of contiguous cell labeling occur in much of the RE (b, c). This can be faint, especially in 11-week OVA animals (c, g), but is indeed present. (f, g) Higher magnification shows that in the RE strips, labeled cells are primarily goblet cells (G) but also include ciliated cells (C) and a few basal cells (B). In most of the OE, labeling remains primarily in scattered basal cells (bracketed turbinate area, upper right, c; e, bracketed region of c rotated and at higher magnification), as in untreated animals. However, especially in RE-adjacent areas, strips of OE labeling also occur (subepithelial dots just dorsal to septal RE, b, c). These strips are generally longer in 11-week OVA than 6-week OVA animals. Labeled cells in the OE strips are primarily supporting (S) and basal (B) cells but can also include scattered cells in the intervening olfactory sensory cell layer. The 11-week OVA animals also show wider nasal distribution of labeled cell strips than 6-week animals (j). These occurred in normally thinner OE (j, dots, here around the concave surface of endoturbinate 1, left, and the lateral dorsal recess, top) as well as some scattered in normally thicker OE (j, double arrowheads). Labeling also appeared in areas showing greater OE disruption (k, l). In both RE and OE labeled cell strips, the labeled nuclei are generally quite swollen, more so at 11 weeks OVA than 6 weeks OVA, leading to greater dispersal of immunoreactivity product through increased nuclear volumes and consequently fainter staining (c, g, i-l) . This contrasts with nuclei of the scattered single labeled basal cells, which remain unswollen and sharply delineated (d, e) . (h, k) Swollen Bowman's glands (BG) showed no BrdU labeling, even subjacent to disrupted OE-containing labeled cells. (l) Few labeled cells (arrowhead) occur in nasal exudate (asterisk). Image brightness of a, c and contrast of j were increased slightly to better show label distribution. Calibration bars, a, 100 lm for a-c, j; d, 10 lm, for d-i; k, 25 lm for k-l.
of variability was generally higher in acutely treated than in chronically treated animals (not shown). Thus, if cyclic alteration in naris patency were sufficient to limit fluid access into the less opened nasal cavity, then acutely treated animals would show lower TUNEL labeling on the less patent side despite delivery of equal fluid volumes to each naris. In contrast, the multiple infusions of chronic treatment would, over the entire experimental time course, lead to cumulative effects in both nasal cavities, resulting in the higher overall labeling levels and lower labeling variability in chronic than in acute animals. With chronic PBS treatment, however, those cumulative effects would reflect only general epithelial damage, not an AR response. If the greatest damage present at the time of sacrifice were due to the most recent PBS delivery, this would still reflect the nasal patency at the time of that final infusion, but now imposed on labeling effects of cumulative damage. In contrast, the chronic OVA multiple infusions would lead to cumulative effects of immune responses in both nasal cavities, evidenced by bilateral eosinophilic infiltration, and to consequently bilateral TUNEL labeling.
Overall TUNEL nasal distribution in both PBS-and OVAchronically treated animals was generally more extensive at Figure 9 Low magnification images showing TUNEL labeling distributions in nasal cavities in animals receiving different exposure regimens. Dots have been added to indicate the location of labeling, seen at higher magnification of the individual images. Dot densities reflect subjective estimates of the labeling densities. Dorsal is up except in h, which has been rotated counterclockwise to show a greater portion of the septum. Untreated animals showed little or no labeling (a). In acutely exposed or chronically PBS-treated animals, labeling is predominantly unilateral (b-d, f) . In contrast, 6-week and more highly labeled 11-week OVA animals show bilateral labeling (e, g). Additionally, however, some 11-week OVA animals show high (g) OE labeling levels, whereas others show low levels (h). The latter often show noticeable TUNEL labeling of sloughed cells in nasal cavity exudate in (arrows, h). Brightness of all images was uniformly increased to enhance labeling visibility. Calibration bar, 200 lm.
Allergic Rhinitis in Nasal Epithelia 9 11 than 6 weeks ( Figure 9f,g vs. d,e) , again likely reflecting greater cumulative effects with longer treatment. However, although some of the 11-week OVA mice showed clearly increased TUNEL labeling relative to chronic PBS mice (Figure 9g ), others showed distinctly less (Figure 9h) . Significantly, the OVA-treated animals with lower labeling also showed the most pronounced OE disruption and cell sloughing, with many sloughed cells being TUNEL positive (arrows, Figures 9h and 10a,b) . This suggests that the lower labeling levels in these mice may actually reflect greater and/ or more rapid loss of damaged cells.
Finally, in further contrast to BrdU, TUNEL-positive cells were noticeably more numerous in OE than RE (Figure 10c ). Specific cell type labeling patterns also differed from BrdU labeling: in the RE, ciliated cells showed greater labeling than goblet or basal cells ( Figure 10d) ; in the OE, most labeling occurred in the OSN layer, although scattered labeling occurred in supporting and basal cell layers as well ( Figure  10e ). Labeled OE cells showed no swelling.
Nasal sinuses
AR-related changes were also noted in the nasal sinuses, including epithelial hypertrophy, subepithelial eosinophil infiltration, and BrdU and TUNEL labeling (See Figures 4, 5) . These are mentioned because sinusitis can similarly lead to olfactory impairment.
Discussion
Our study examined murine nasal epithelial changes following AR induction using the McCusker nasal sensitization and challenge protocol (McCusker et al. 2002) . AR induction was indicated by high OVA-specific IgE serum levels and eosinophil infiltration and occurred only in chronically OVA-exposed animals.
The most striking finding was the localization in chronic OVA animals of eosinophil infiltration to the immediate RE-subjacent, but not OE-subjacent, lamina propria. Similar eosinophilic localization has been previously noted and preliminarily investigated in mice by Hussain et al. (2001) using quite different AR sensitization and challenge protocols, but received little further attention. With interest focused on AR per se, Hussain et al. and the few others who subsequently cite them (Hussain et al. 2002; Sasaki et al. 2007; Hayahashi et al. 2008) simply limited investigation to RE-only nasal regions, with minimal examination of localization specificity. Other AR researchers, using various allergens and protocols in a variety of species, have either made no distinction between OE and RE or examined only the RE without further comment (e.g., Tanaka et al. 1988; Takahashi et al. 1990; Ishida et al. 1993; Asakura et al. 1998; van de Rijn et al. 1998; Okano et al. 1999; McCusker et al. 2002; Lin et al. 2010) . Much AR literature has also focused on human nasal tissue; and although eosinophil involvement is well known from nasal swab and mucus preparations or biopsies, those sampling methods provide no explicit information on eosinophil tissue localization. Overall, such inadequacies have led to limited awareness or concern about RE/OE eosinophil localization specificity in AR.
A few reports of eosinophil infiltration of OE-associated tissue do exist, but those raise other issues. Using OVA as the allergen, Ozaki et al. (2010) reported significant infiltration of OE lamina propria by eosinophils and other inflammatory cell types. However, lack of clarity as to OE versus RE identity and nasal distribution were apparent in that report. Moreover, a very different immunization protocol from our own was followed, including use of 2000 times the OVA infusion amount that could lead to other, non-AR responses (McCusker et al. 2002) . Finally, in our own laboratory, Epstein et al. (2008) found OE eosinophil infiltration following nasal sensitization to Aspergillis fumigatus extract. Observed responses, however, included large increases in OE apoptosis 12-18 h after single infusions of extract in absence of previous sensitization. This suggests involvement of additional, nonallergenic responses, such as innate responses to fungal microbe-associated molecular patterns, a concern whenever microbially derived or associated allergens are used.
Although we did not verify the full extent of infusate nasal dispersion, for example, by examining perfused vital dye nasal distribution, the observed eosinophil RE localization does not seem due simply to inadequate OVA access to the OE during infusion. First, RE-associated eosinophil localization occurred uniformly throughout the entire nasal cavity, anteriorly, posteriorly, and laterally and in RE-bearing concave turbinate surfaces. Other, specifically OE-associated changes, such as Bowman's gland swelling and altered OE TUNEL labeling, were also uniformly distributed. Second, limited OVA nasal distribution would also not explain the uniformly abrupt change in sublaminal eosinophil infiltration seen across all RE/OE transition zones in all chronic OVA animals. Finally, the similar observations of Hussain et al. (2001) occurred with systemic adjuvant-enhanced OVA sensitization and 2 different nasal challenge protocols from our own, one a continuous 20 min exposure to nebulized OVA twice a day 6 days apart, the other a daily intranasal OVA infusion for 10 days. Thus, although without definitive verification we cannot guarantee that OVA solution uniformly reached all parts of the nasal cavity with each individual application, the RE-specific subepithelial eosinophil infiltration does appear real.
The cause for this localization specificity is unknown. In preliminary examination, Hussain et al. (2001) found no differential RE versus OE immunostaining for either I-CAM-1 or eotaxin. Those factors were examined because of their known induction in human AR and possible roles, respectively, in transepithelial eosinophil migration and as an eosinophil cytokine. Within the RE itself, ciliated cells can interact with allergens (Locksley 2010) to initiate local allergic responses (Coffman 2010) . Goblet cells can also be involved (Rogers 2003) . Thus, subsequently released eosinophil attractants might be localized within RE-associated lamina propria. Alternatively, OE mucosa may in some way block sub-OE eosinophil infiltration or OE and RE may provide differential transepithelial allergen access. Absence of OE-associated eosinophil infiltration might protect the OE from inflammatory processes, thereby representing an extension of the immune privilege of various neural tissues. Examination of distribution specificities of other immune cell types, including mast cells, basophils, neutrophils, macrophages, and T H 2 cells, as well as related RE versus OE cytokine and cytokine receptor analysis, are needed.
Also curious was the absence of large-scale OE cell loss (only 20%), thinning, or disruption in the chronic OVA animals except at localized sites, especially given the high levels of OE TUNEL, limited increases in BrdU labeling, and absence of spatial and temporal BrdU and TUNEL overlap. Hussain et al. (2001) also observed relatively little AR-induced OE damage. Given the massive OSN death and replacement following direct OSN surgical and chemical damage (e.g., Graziadei and Monti Graziadei 1978; Carr and Farbman 1992; Schwob et al. 1995) , greater general OE cell loss and thinning were expected.
We have no ready explanation for these observations. Some specifically AR-associated OE TUNEL labeling may reflect elimination of metaplastic RE cells from the OE as a means of maintaining OE integrity and maximizing olfactory function under AR conditions. Different mechanisms regulating spatial and temporal correlation of OSN cell death and replacement, such as an increased role for active extrusion of damaged cells, may also be involved in AR. As noted, animals showing the fewest TUNEL-positive OE cells showed the greatest OE disruption and cell sloughing, with many extruded cells being TUNEL positive. Specifically decreased epithelial intercellular adhesion has indeed been reported in bronchial asthma (Trautmann et al. 2005) ; and specific targeting of degenerating cells for extrusion has been hypothesized to enhance epithelial barrier maintenance in other tissues (Rosenblatt et al. 2001) . It may also explain the apparently increased OE tearing in chronic OVA mice.
It is also possible that some TUNEL labeling may reflect false positive labeling (Stähelin et al. 1998; Sloop et al. 1999; Pulkkanen et al. 2000; Walker and Quirke 2001) . However, this was carefully monitored. Proteinase K and TdT concentrations were adjusted to minimize background labeling in neighboring tissues and olfactory bulbs. Observed responses were also specific to the epithelia and nasal location, including side-to-side differences in PBS-and acutely OVA-exposed animals and occurrence of only minimal labeling in untreated controls. Finally, sections from previously unilaterally bulbectomized mice (Robinson et al. 2003 ) processed in parallel with sections from the current study showed appropriately increased TUNEL labeling in ipsilateral OE. Labeling might also reflect necrosis although no macrophage influx or swelling of labeled cells was observed.
Despite the absence of major generalized OE disruption, AR-related OE changes clearly occur. These include localized areas of disruption and major thinning and others of cellular hypertrophy, as well as the Bowman's gland hypertrophy, BrdU and TUNEL labeling, and cell sloughing discussed above. At least some of these changes may be RE-mediated, suggesting the possibility of unexpected RE/ OE interactions. One such change is OE BrdU uptake. At 6 weeks of OVA exposure, OE BrdU labeling occurs primarily in more RE-proximal OE and areas of normally thinner OE; by 11weeks exposure, it is more widespread. Most of the thinner OE where labeling occurs lies laterally and on turbinate shafts, where nasal architecture is somewhat complex and might serve to localize any factors released by nearby RE or any RE-associated immune cells. As resulting local OE damage ensues, possible OE replacement by RE (Yee et al. 2009 ) could increase concentrations of such factors, leading to the increasingly widespread labeling. An extreme example of RE-proximal OE effects may be the disappearance of the RE-surrounded septal organ. Such RE-associated OE effects would also contribute to AR interanimal variability.
Other OE changes may be more locally generated. For example, olfactory nerve compression has been hypothesized to cause retrograde OSN damage in a genetically induced murine rhinosinusitis model (Lane et al. 2010) . Swollen Bowman's gland crowding of olfactory nerve bundles and swelling into the OE itself might similarly cause OSN damage in the current study. Certainly, olfactory nerve bundle axonal packing densities are less. Bowman's glands and olfactory nerve ensheathing cells also release immune barrier-associated agents (Getchell ML and Getchell TV 1991; Allergic Rhinitis in Nasal Epithelia 11 Mellert 1991; Vincent et al. 2005; Débat et al. 2007 ) that might further affect the OE. Supporting cells, which show a variety of responses to many OE insults (Suzuki et al. 1995 (Suzuki et al. , 1996 Carr et al. 2001; Carr 2005; Jia et al. 2009 ), may also be involved. Supporting cell electrical coupling (Vogalis et al. 2005 ) might also be related to the apical OE strips of contiguous BrdU cell labeling seen after chronic OVA.
In the RE, TUNEL levels were noticeably low in many AR animals. Interestingly, observations in several species and a variety of inflammatory conditions indicate that airway goblet cell hyperplasia is associated with increased expression of antiapoptotic Bcl-2 (Tesfaigzi et al. 1998 (Tesfaigzi et al. , 2000 Harris et al. 2005 ) and loss of proapoptotic Bim (Pierce et al. 2006) , maximizing goblet cell numbers and subsequent mucus secretion. Significantly, with termination of allergen exposure, goblet cell Bcl-2 expression decreases and metaplastic goblet cells disappear from airway mucosae. Analysis of RE TUNEL levels and temporal patterns of any changes following cessation of OVA exposure in AR animals would be of interest.
Our findings also demonstrate that changes were induced by PBS alone, including TUNEL labeling and slight RE swelling with PBS and acute OVA and slight Bowman's gland hypertrophy with chronic PBS. All occurred in absence of eosinophil infiltration, BrdU uptake, or other histological changes. The slight RE and Bowman's gland swelling likely reflect their involvement in increased mucus synthesis, with its protective and olfactory functions (Getchell and Mellert 1991; Rogers 2003; Débat et al. 2007 ), directed at restoring normal nasal fluid composition after PBS infusion. The TUNEL findings likely reflect fluid infusion-related tissue stress, as described. Whether these reflect specific PBS tonicity, composition, or pH effects or purely mechanical effects of fluid infusion is unclear.
Finally, the amount of any olfactory functional loss in the current model is unknown and needs to be addressed, using both olfactory bulb activity markers and behavioral studies. The lack of major histological OE changes, the significant goblet cell hypertrophy and hyperplasia, and obvious presence of nasal mucus in the 11-week OVA animals, however, suggest that any effects would likely be due predominantly to diminished odorant access to the OE, that is, conductive rather than sensorineural in nature (Snow 1991) . This is supported by findings in the Ozaki et al. (2010) study, showing impaired olfactory function and lower olfactory bulb tyrosine hydroxylase immunostaining despite only minor OE histological changes and no change in bulb OMP immunostaining. Sensorineural effects, however, might also be involved, depending on the degrees of OSN damage from Bowman's gland olfactory nerve bundle compression, of increasing OE damage with increased OVA exposure time, and of any neuroma formation. The last was seen in both Series I 11-week OVA mice (not shown).
In conclusion, our study has demonstrated tissue-specific OE and RE effects of AR. It also leaves many questions unanswered: the array of immune cells involved, their specific nasal localizations, and epithelial-specific effects of agents released by each; chemokine and cytokine receptor distributions; different allergens and allergen dosage effects; degree of goblet cell OE metaplasia; recovery time after cessation of chronic allergen exposure; identity and roles of constituent OE cells involved; analysis of OSN cell death versus replacement; and analysis of induced AR on olfactory capability. Species and strain specificities also need further study. Addressing these questions will help clarify the immune system, RE, and OE interactions involved.
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